IMMUNOVANT INC. - CO
29.40
07-十月-24 14:59:58
15 分钟延时
股票
-1.11
-3.64%
今日范围
28.92 - 30.58
ISIN
N/A
来源
NASDAQ
-
Immunovant Reports Financial Results for the Quarter Ended September 30, 2021
05 11月 2021 06:30:00 条件 Nasdaq GlobeNewswire
-
Immunovant to Participate in Roivant R&D Day 2021
27 9月 2021 07:00:00 条件 Nasdaq GlobeNewswire
-
Immunovant Appoints Renee Barnett as Chief Financial Officer
15 9月 2021 06:00:01 条件 Nasdaq GlobeNewswire
-
Immunovant Reports Financial Results for the Quarter Ended June 30, 2021
09 8月 2021 05:30:00 条件 Nasdaq GlobeNewswire
-
Immunovant to Report Financial Results for Quarter Ended June 30, 2021
06 8月 2021 15:22:27 条件 Nasdaq GlobeNewswire
-
Immunovant Receives $200 Million Strategic Investment from Roivant Sciences
02 8月 2021 06:30:00 条件 Nasdaq GlobeNewswire
-
01 6月 2021 06:31:18 条件 Nasdaq GlobeNewswire
-
Immunovant Reports Financial Results for the Quarter and Nine Months Ended December 31, 2020
16 2月 2021 07:00:04 条件 Nasdaq GlobeNewswire
-
Immunovant Announces Voluntary Pause in Clinical Dosing of IMVT-1401
02 2月 2021 05:30:00 条件 Nasdaq GlobeNewswire
-
Immunovant Appoints Rita Jain Chief Medical Officer And Provides Corporate Update
12 1月 2021 16:00:00 条件 Nasdaq GlobeNewswire